Mezi S, Reale M G, Aloise G, Marchei C G, Marigliani A, Del Nero A, Manna A, Modesti M
Istituto di III Clinica Chirurgica Generale e Terapia Chiurgica, Università degli Studi La Sapienza, Roma.
G Chir. 1995 Jan-Feb;16(1-2):19-25.
Ca 15-3 was assayed in serum and in breast cysts fluid of 78 non neoplastic patients presenting Gross Cysts (GCD). In apocrine cysts and in the mixed type (serous and apocrine, class III) relapse was indicated by high serum and intracystic levels of the marker. Ca 15-3, therefore, may discriminate in a group of cysts a higher cellular resistance as well as an increased cell proliferation. Results suggest an important role of the marker in the follow up of patients with GCD and for the early detection of cyst relapse.
对78例有大囊肿（GCD）的非肿瘤患者的血清和乳腺囊肿液进行了Ca 15-3检测。在大汗腺囊肿和混合型（浆液性和大汗腺，III类）中，血清和囊内标志物水平升高提示复发。因此，Ca 15-3可能在一组囊肿中区分出更高的细胞抵抗力以及增加的细胞增殖。结果表明该标志物在GCD患者的随访和囊肿复发的早期检测中具有重要作用。
